Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Metlife (MET) Shares Outstanding (Weighted Average) (2016 - 2026)

Metlife's Shares Outstanding (Weighted Average) history spans 18 years, with the latest figure at $652.0 million for Q1 2026.

  • Quarterly Shares Outstanding (Weighted Average) fell 4.44% to $652.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $652.0 million through Mar 2026, down 4.44% year-over-year, with the annual reading at $668.9 million for FY2025, 5.31% down from the prior year.
  • Shares Outstanding (Weighted Average) came in at $652.0 million for Q1 2026, down from $668.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $823.8 million in Q1 2022 to a low of $652.0 million in Q1 2026.
  • The 5-year median for Shares Outstanding (Weighted Average) is $723.2 million (2024), against an average of $734.1 million.
  • Year-over-year, Shares Outstanding (Weighted Average) dropped 7.8% in 2024 and then dropped 3.83% in 2025.
  • Metlife's Shares Outstanding (Weighted Average) stood at $803.2 million in 2022, then dropped by 5.66% to $757.7 million in 2023, then decreased by 6.77% to $706.4 million in 2024, then decreased by 5.31% to $668.9 million in 2025, then dropped by 2.53% to $652.0 million in 2026.
  • Per Business Quant, the three most recent readings for MET's Shares Outstanding (Weighted Average) are $652.0 million (Q1 2026), $668.9 million (Q4 2025), and $672.5 million (Q3 2025).